Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryClinical TrialClinical Development

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758183

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758183

Diverticulitis Disease

PUBLISHED:
PAGES: 294 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Diverticulitis Disease Market to Reach US$2.6 Billion by 2030

The global market for Diverticulitis Disease estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Medications Treatment, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$666.1 Million by the end of the analysis period. Growth in the Surgery Treatment segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$489.1 Million While China is Forecast to Grow at 10.3% CAGR

The Diverticulitis Disease market in the U.S. is estimated at US$489.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$542.3 Million by the year 2030 trailing a CAGR of 10.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Diverticulitis Disease Market - Key Trends & Drivers Summarized

Why Is Diverticulitis Garnering Growing Medical Attention Worldwide?

The global diverticulitis disease market is experiencing heightened interest due to the increasing prevalence of gastrointestinal disorders and the rising demand for effective treatment solutions. Diverticulitis, a condition characterized by inflammation or infection of diverticula in the digestive tract, is becoming more common, particularly in aging populations and in regions adopting Western dietary habits. Sedentary lifestyles, low-fiber diets, and obesity are significant contributing factors to the rise in incidence. As healthcare systems globally improve diagnostic capabilities, more cases are being identified at earlier stages, leading to a broader patient base in need of medical intervention. The clinical spectrum of the disease-from uncomplicated cases to those requiring surgical procedures-has expanded the therapeutic landscape, encompassing antibiotics, anti-inflammatory medications, dietary modifications, and increasingly, advanced surgical treatments. The growing burden on healthcare resources, coupled with an aging demographic, has positioned diverticulitis as a condition of both clinical urgency and commercial opportunity, especially in developed nations.

How Are Diagnostics and Treatments Evolving in Response to Changing Demographics?

Rapid advancements in imaging technologies and diagnostic procedures are enabling more accurate detection and classification of diverticulitis, which is crucial for targeted treatment. High-resolution CT scans and colonoscopies are now standard diagnostic tools, allowing for differentiation between simple and complicated cases. On the treatment front, there is a significant shift toward non-invasive and outpatient management strategies, especially for mild to moderate cases. Antibiotic stewardship programs are encouraging physicians to limit unnecessary antibiotic use, leading to refined treatment protocols. Simultaneously, research is ongoing into novel anti-inflammatory agents and biologics that could provide targeted relief with fewer side effects. In severe cases, minimally invasive surgeries like laparoscopic resection are becoming more common, reducing hospital stays and recovery times. Nutritional therapy and fiber supplementation also play essential roles in recurrence prevention, and these aspects are being increasingly integrated into patient management plans. This confluence of better diagnostics and diversified treatments is reshaping the standard of care for diverticulitis worldwide.

Which Populations and Markets Are Driving Demand for Diverticulitis Solutions?

North America and Europe are the most mature markets for diverticulitis treatment, primarily due to high disease prevalence, established healthcare infrastructure, and strong awareness among both patients and practitioners. The United States, in particular, exhibits the highest incidence rates, attributed to dietary patterns and aging baby boomers. Europe follows closely, with countries like Germany and the UK implementing robust screening and surgical programs. In Asia-Pacific, the market is expanding rapidly due to urbanization, increasing disposable incomes, and greater access to healthcare services. Emerging markets such as India and China are witnessing a steady rise in cases, driven by shifts in diet and lifestyle. These regions are also investing in hospital infrastructure and medical training, leading to improved diagnostic and treatment capabilities. Latin America and the Middle East are nascent markets with rising awareness and increasing investments in gastrointestinal care. Across all regions, the demand for personalized and value-based care models is influencing treatment patterns and reimbursement strategies.

What Are the Key Factors Driving Market Growth?

The growth in the diverticulitis disease market is driven by several factors, including the rising prevalence of gastrointestinal disorders associated with aging populations and dietary changes, particularly in urbanized areas. Advances in diagnostic imaging technologies and increased access to colonoscopy screenings are enabling earlier and more accurate diagnoses, expanding the base of treated patients. Changes in clinical guidelines emphasizing conservative management have increased the role of pharmaceuticals, creating opportunities for drug manufacturers. Simultaneously, the expansion of minimally invasive surgical techniques has boosted the demand for surgical instruments and robotic systems. Growing patient awareness, combined with greater health literacy and demand for outpatient care, is reshaping the way diverticulitis is managed across healthcare settings. The development of new pharmaceutical agents targeting inflammation and gut microbiota modulation is also fueling innovation in the treatment pipeline. Moreover, the integration of gastrointestinal care into broader chronic disease management frameworks is reinforcing its strategic importance within global healthcare systems.

SCOPE OF STUDY:

The report analyzes the Diverticulitis Disease market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment, Other Treatments); End-Use (Specialty Centers End-Use, Hospitals End-Use, Research Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Allergan (AbbVie)
  • AstraZeneca
  • Bausch Health Companies
  • Baxter International
  • Bristol-Myers Squibb
  • Ferring Pharmaceuticals
  • Gilead Sciences
  • GlaxoSmithKline (GSK)
  • Johnson & Johnson
  • Medtronic
  • Mylan (Viatris)
  • Novartis
  • Pfizer
  • Roche
  • Sanofi
  • Sandoz (Novartis)
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
  • UCB

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP36745

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Diverticulitis Disease - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Digestive Disorders Drives Market for Diverticulitis Treatment
    • Aging Global Population Spurs Growth in Diverticulitis Diagnoses and Therapies
    • Increasing Use of Minimally Invasive Surgical Techniques Strengthens Treatment Options
    • Advances in Imaging and Diagnostic Tools Propel Early Detection Rates
    • Growing Awareness Campaigns Highlight Disease Management and Drive Patient Volumes
    • Lifestyle Changes and Poor Dietary Habits Sustain Disease Incidence
    • High Demand for Personalized Medicine Expands Market for Targeted Therapies
    • Availability of Advanced Antibiotics Enhances Recovery Outcomes and Drives Adoption
    • Integration of AI and Predictive Analytics in Diagnostics Generates Growth Potential
    • Increased Healthcare Spending in Developing Regions Expands Access to Treatment
    • Innovation in Biologic and Anti-Inflammatory Drugs Strengthens Pipeline Prospects
    • Recurrence Prevention Strategies Drive Demand for Long-Term Management Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Diverticulitis Disease Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Diverticulitis Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Diverticulitis Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Diverticulitis Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Medications Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Medications Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Medications Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Surgery Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Supportive Care Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Supportive Care Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Supportive Care Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Antibiotics Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Antibiotics Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Antibiotics Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Dietary Supplements Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Dietary Supplements Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Dietary Supplements Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Specialty Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Specialty Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Diverticulitis Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Diverticulitis Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Diverticulitis Disease by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Diverticulitis Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Diverticulitis Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Diverticulitis Disease by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Diverticulitis Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Diverticulitis Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Diverticulitis Disease by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Diverticulitis Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Diverticulitis Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Diverticulitis Disease by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Diverticulitis Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Diverticulitis Disease by Treatment - Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Diverticulitis Disease by Treatment - Percentage Breakdown of Value Sales for Medications Treatment, Surgery Treatment, Supportive Care Treatment, Antibiotics Treatment, Dietary Supplements Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Diverticulitis Disease by End-Use - Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Diverticulitis Disease by End-Use - Percentage Breakdown of Value Sales for Specialty Centers End-Use, Hospitals End-Use and Research Centers End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!